Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 10 results

Search term: MF = 'C_{26}H_{30}ClF_{3}N_{2}O_{4}'
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
22748301

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClF3N2O4/c1-2-35-25(34)12-11-24(33)32-15-13-31(14-16-32)17-23(20-5-9-22(27)10-6-20)36-18-19-3-7-21(8-4-19)26(28,29)30/h3-10,23H,2,11-18H2,1H3
C26H30ClF3N2O4526.97567600
22748302

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClF3N2O4/c1-35-25(34)4-2-3-24(33)32-15-13-31(14-16-32)17-23(20-7-11-22(27)12-8-20)36-18-19-5-9-21(10-6-19)26(28,29)30/h5-12,23H,2-4,13-18H2,1H3
C26H30ClF3N2O4526.97567600
28656618

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22+,23-,24+/m1/s1
C26H30ClF3N2O4526.97565400
29401876

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22+,23+,24-/m1/s1
C26H30ClF3N2O4526.97564400
58159459

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22-,23+,24-/m1/s1
C26H30ClF3N2O4526.97562200
58160720

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22-,23-,24+/m1/s1
C26H30ClF3N2O4526.97562200
58161638

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22+,23+,24-/m0/s1
C26H30ClF3N2O4526.97562200
68390471

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClF3N2O4/c1-19-14-21(8-9-22(19)27)35-18-25(15-24(34)31(2)16-20-6-4-3-5-7-20)17-32(12-13-36-25)23(33)10-11-26(28,29)30/h3-9,14H,10-13,15-18H2,1-2H3
C26H30ClF3N2O4526.97562100
30658620

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C17H19F3N2.C8H7ClO3.CH4O/c1-9-13-8-21-5-4-10(13)6-15-16(9)12-7-11(17(18,19)20)2-3-14(12)22-15;9-6-4-2-1-3-5(6)7(10)8(11)12;1-2/h2-3,7,9-10,13,21-22H,4-6,8H2,1H3;1-4,7,10H,(H,11,12);2H,1H3/t9-,10-,13-;7-;/m11./s1
C26H30ClF3N2O4526.97561100
9516432

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C24H29ClN2O2.C2HF3O2/c1-16-6-4-9-22(18-7-5-8-19(25)14-18)23(16)26-24(28)29-15-17-12-20-10-11-21(13-17)27(20,2)3;3-2(4,5)1(6)7/h4-9,14,17,20-21H,10-13,15H2,1-3H3;(H,6,7)
C26H30ClF3N2O4526.97561100

Advertisement